These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 13643848)
41. Anticoagulant therapy in private practice. STEPHENS CA Circulation; 1954 May; 9(5):682-6. PubMed ID: 13161099 [No Abstract] [Full Text] [Related]
42. Some practical aspects of anticoagulant therapy. LOWENSTEIN L; SHAPIRO L AMA Arch Surg; 1955 Jan; 70(1):98-104. PubMed ID: 13217609 [No Abstract] [Full Text] [Related]
43. Further experience with long-term anticoagulant therapy. FOLEY WT; McDEVITT E; SYMONS C; WRIGHT IS AMA Arch Intern Med; 1955 Apr; 95(4):497-502. PubMed ID: 14360825 [No Abstract] [Full Text] [Related]
44. [Oral anticoagulants in cardiac patients undergoing elective surgical procedures: what attitude to adopt?]. Yerly P; Schapira M; Vogt P Rev Med Suisse; 2005 May; 1(21):1412-4, 1416-7. PubMed ID: 15997979 [TBL] [Abstract][Full Text] [Related]
45. [Anticoagulant therapy of thromboembolic diseases with special reference to phenindione]. REMDE W Dtsch Gesundheitsw; 1953 Nov; 8(45):1371-6. PubMed ID: 13116730 [No Abstract] [Full Text] [Related]
46. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Singhal R; Brimble KS Thromb Res; 2006; 118(3):397-407. PubMed ID: 15990160 [TBL] [Abstract][Full Text] [Related]
47. Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases. Turpie AG Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1238-47. PubMed ID: 17379841 [TBL] [Abstract][Full Text] [Related]
48. [Congenital cardiopathy: indications for anticoagulant treatment]. Losay J; Touchot-Koné A; Lambert V Arch Mal Coeur Vaiss; 2005 May; 98(5):566-70. PubMed ID: 15966610 [TBL] [Abstract][Full Text] [Related]
49. Chronic anticoagulant therapy in recurrent embolism of cardiac origin. COSGRIFF SW Ann Intern Med; 1953 Feb; 38(2):278-87. PubMed ID: 13017439 [No Abstract] [Full Text] [Related]
50. [Clinical experiences with the anticoagulant effects of a polycarbonic acid preparation]. DOPKE G Munch Med Wochenschr; 1955 Sep; 97(37):1218-9. PubMed ID: 13265726 [No Abstract] [Full Text] [Related]
51. [Anticoagulants and cancer: beyond thromboembolic disease prevention]. Jornayvaz FR; Perrier A Rev Med Suisse; 2006 Oct; 2(83):2350-3. PubMed ID: 17112086 [TBL] [Abstract][Full Text] [Related]
52. [Effect of anesthesia and anticoagulant prophylaxis on the occurrence of postoperative thromboembolic complications in orthopedic patients]. Neĭmark MI; Zinovv'eva IE; Deev IT; Dicheskul ML; Smirnova OI; Momot AP Anesteziol Reanimatol; 2006; (2):35-8. PubMed ID: 16758942 [TBL] [Abstract][Full Text] [Related]
53. Audit of community-based anticoagulant monitoring in patients with thromboembolic disease: is frequent testing necessary? Young L; Ockelford P; Harper P Intern Med J; 2004 Nov; 34(11):639-41. PubMed ID: 15546458 [TBL] [Abstract][Full Text] [Related]
54. Venous thromboembolism in the ICU and reversal of bleeding on anticoagulants. DeLoughery TG Crit Care Clin; 2005 Jul; 21(3):497-512. PubMed ID: 15992670 [TBL] [Abstract][Full Text] [Related]
55. Present status of anticoagulant therapy. SEAMAN AJ GP; 1960 Oct; 22():135-48. PubMed ID: 13749479 [No Abstract] [Full Text] [Related]
56. The use of anticoagulants in surgical problems. OLWIN JH; KOPPEL JL Surg Clin North Am; 1959 Feb; 39(1):193-201. PubMed ID: 13625093 [No Abstract] [Full Text] [Related]